QORAQALPOG'ISTON RESPUBLIKASIDA BACHJDON BO'YINI SARATONINI SKRINING BO'YICHA PILOT LOYIHASINING BIRINCHI TUR NATIJALARI
##article.subject##:
skrining, bachadon bo'yni saratoni, inson papillomavirusi turlari, kolposkopiya##article.abstract##
Bachadon bo'yni saratoni ayollar o'rtasidagi kasallanish va o'lim darajasi bo'yicha ham global, ham mintaqaviy miqyosda 2-o'rinda turadi. Bugungi kunga kelib, bachadon bo'yni saratonini oldini olish borasida amaldagi texnologiyalar mavjud, ya'ni odam papillomavirusga qarshi emlash, bachadon bo'ynining saraton oldi holatlarni erta aniklash va davolash. Bachadon bo'yni saratonini эрта aniqlash uchun eng samarali skrining bu 30-49 yoshdagi ayollarni odam papillomavirusining (HPV) onkogen turlariga tekshirishdir. Qoraqalpog‘iston Respublikasida 30-55 yoshdagi 49 002 nafar ayollarda HPV testini o‘tkazdik, shundan 3307 nafar ayolda (6,8 %) test natijasi musbat (HPV+) bulib, 45 695 nafar аёлда (93,2 %) HPV aniklanmadi. (test natijasi – manfiy). Barcha HPV+ orasida 33,6% hollarda P1 (virusni 16- turi), 24,2%dа - P3 (31, 33, 35, 52-turlarи), 18,6%dа - P5 (39, 56, 66-turlarи), 11,6% dа - P4 (51,59 turlarи), 7,6% dа - P2 (18,45-turlarи) vа 9,4% da viruslar birikmasi bulib, Qoraqalpog‘istonda eng keng tarqalgan turi HPV16 ligi aniklandi. HPV musbat ayollarga kengaytirilgan kolposkopiya va aniqlangan saraton-oldi holatlarni davolash amaliyoti bajarildi. Shuni ta'kidlash kerakki, barcha HPV+ va davolangan ayollarda hech qanday shikoyat va klinik ko'rinishlar bo'lmagan. Shunday qilib, HPV- testi yordamida utkazilgan skrining natijalari O'zbekiston Respublikasi uchun vakillidir. HPV testi бачадон буйни saraton-oldi va saraton kasalliklarini erta tashxislashda samarali skrining usuli hisoblanadi.
Библиографические ссылки
Всемирная организация здравоохранения. Вирус папилломы человека и рак шейки матки. ВОЗ; 2022. https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
Коннон С.Р.Д., Союнов М.А. Рак шейки матки: профилактика и скрининг (новые данные). Акушерство и гинекология: новости, мнения, обучения. 2018. Т.6, №3. С.72-82.
Минкин Г.Н. Цитологический скрининг рака шейки матки: от традиционного Пап-теста к компьютерным технологиям. Акушерство, гинекология и репродукция. 2017; 11 (1): 56–63.
Протокол пилотной программы скрининга рака шейки матки в Узбекистане. Ташкент. Октябрь 2020г. стр. 22
AGO-ASCCP Use of Primary High-Risk HPV-Testing for Cervical Cancer Screening: Interim Clinical Guidance, 2015;
Philip Davies. HPV Primary Cervical Screening Pilot in the Republic of Uzbekistan Analysis of Outcomes and Recommendations to Maximise the Collection of Data Required to Design and Implement a National Cervical Cancer Screening Program. 2022.
Lei et al. HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 2020; 383:1340-8. DOI: 10.1056/NEJMoa1917338
SOGC/SCG. Colposcopic Management of abnormal cervical cancer screening and histology. Clinical Practice Guideline/ 2015. -P. 34
S. Arrossi, S. Temin, S. Garland, L. Eckert and et. Primary Prevention of cervical cancer: American Society of clinical oncology resource-stratified Guideline// Journal of Global Oncology. - 2017.-Volume 5, issue 3. P.1-24
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021:71:209–49. doi:10.3322/caac.21660.
T.Terasawa, S.Hosono, S.Sasaki, K.Hoshi et all. Comparative accuracy of cervical cancer screening strategies in healthy asymptomatic women a systematic review and network meta-analysis. Scientific Reports. Nature portfolio. 2022
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem https://www.who.int/publications/i/item/9789240014107
WHO guidance note: comprehensive cervical cancer prevention and control: a healthier future for girls and women. 2014. 16 р.
